UAB is a clinical site for the A4 Study of Alzheimer’s disease, recently featured in Newsweek magazine.
The Alzheimer’s plaques that accumulate around brain cells also congregate along the walls of blood vessels, according to UAB research, and that may contribute to cognitive issues.
UAB has launched one of the first clinics in the nation designed to provide healthy adults with an assessment of their risk for Alzheimer’s disease.
Neurologist David Geldmacher, M.D., is launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
Study authors say manipulating hormonal signals could effectively counter age-related cognitive decline.